| Patents for C07C 405 - Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins (3,702) |
|---|
| 07/04/2002 | US20020087025 Cobalt-mediated cyclization, in which a complex is formed with the alkynyl group of the starting compound, which decomposes upon heating to form a tricyclic structure |
| 07/03/2002 | EP1219601A1 Prostaglandin derivatives |
| 07/03/2002 | EP1219600A1 Prostaglandin derivatives |
| 07/03/2002 | EP0983235B1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 07/03/2002 | EP0983234B1 Leukotriene b 4 derivatives, in particular 7-methylcyclohexyl-ltb 4 antagonists |
| 07/02/2002 | US6414022 Cyclopentane(ENE)heptenoic or heptenoic acids and derivatives thereof useful as therapeutic agents |
| 06/26/2002 | CN1355788A 前列腺素e1衍生物 E1 prostaglandin derivative |
| 06/25/2002 | US6410780 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 06/25/2002 | US6410591 Vision defects |
| 06/19/2002 | CN1354622A Prostaglandin compound, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 06/11/2002 | US6403649 Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 06/05/2002 | EP1211242A1 Prostaglandin derivatives |
| 06/05/2002 | EP1211241A1 Prostaglandin e analogues |
| 05/28/2002 | US6395787 Prostaglandin f2a 1-ethanolamide derivatives; vision defects |
| 05/28/2002 | US6395786 Sleep inducing agent |
| 05/22/2002 | CN1350521A C16 unsaturated FP-selective prostaglanding analogs |
| 05/14/2002 | US6388128 Stannane synthesis of prostanoids |
| 05/14/2002 | CA2129287C Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension |
| 05/08/2002 | CN1084189C Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 05/07/2002 | CA2129537C Process for the preparation of e-prostaglandins |
| 04/18/2002 | WO2001055101A3 A new process for the preparation of latanoprost |
| 04/17/2002 | CN1345323A Novel intermediate for synthesis of prostaglandins |
| 03/28/2002 | WO2002024639A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | WO2001058866A3 Ocular hypotensive lipids |
| 03/28/2002 | US20020037914 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 03/28/2002 | US20020037913 Prostaglandin F analogs for treating bone disorders and glaucoma; selective for specific receptors |
| 03/28/2002 | CA2433157A1 Cyclopentane derivatives as therapeutic agents |
| 03/27/2002 | EP0874816B1 Process for the preparation of prostaglandin e1 |
| 03/26/2002 | CA2183486C Prostaglandin derivatives |
| 03/19/2002 | US6359181 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 03/05/2002 | US6353000 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
| 02/21/2002 | WO2001074313A3 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 02/06/2002 | EP0912507B1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
| 02/05/2002 | US6344581 Method of prostaglandin synthesis |
| 02/05/2002 | US6344478 Mixture with carbonic anhydrase inhibitor |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/10/2002 | US20020004524 Administering 15-keto-prostaglandin |
| 01/09/2002 | EP1170286A1 Prostaglandin e1 derivatives |
| 01/09/2002 | EP1169467A1 Process for the preparation of prostaglandin precursors |
| 01/09/2002 | EP1169325A1 Novel intermediate for the synthesis of prostaglandins |
| 01/03/2002 | US20020002150 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 01/02/2002 | EP1164846A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 01/02/2002 | EP0665751B1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| 12/26/2001 | CN1076605C Drug for treating hepato biliary diseases |
| 12/12/2001 | EP0662075B1 Prostaglandin analog for treating osteoporosis |
| 12/11/2001 | US6329539 Prostagladin derivatives |
| 12/11/2001 | CA2016300C Prostaglandin i analogue |
| 12/05/2001 | EP1159266A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP0789687B1 Ep2-receptor agonists as agents for lowering intraocular pressure |
| 11/29/2001 | US20010046982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 11/28/2001 | EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 11/06/2001 | US6313341 Process for the preparation of prostaglandins |
| 10/30/2001 | US6310257 Substituted cyclopentene derivatives and method for preparing the same |
| 10/30/2001 | US6310087 Treating gastric or duodenal ulcer, osteoporosis, constipation, renal disorders, sexual dysfunction, baldness, diabetes, cancer and disorder of immune regulation |
| 10/23/2001 | US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma. |
| 10/18/2001 | WO2001076593A2 Bile secretion promoting composition a 15-keto prostaglandin |
| 10/16/2001 | US6303658 Therapy of ocular hypertension by applying cyclopentane heptenoic acid or heptanoic acid and/or derivative |
| 10/11/2001 | WO2001074313A2 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins |
| 09/25/2001 | US6294679 Chemical intermediate |
| 09/20/2001 | US20010023258 Mixture with carbonic anhydrase inhibitor |
| 09/13/2001 | WO2001066518A1 φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E-ALCOHOLS, PROCESS FOR PRODUCING THE SAME AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 09/12/2001 | CN1312796A 5-thia-omega-substituted phenyl-prostaglandin E derivatives, process for producing same and drugs containing same as active ingredient |
| 09/11/2001 | US6288119 11,15-O-dialkylprostaglandin E derivatives, process for producing the same, and drugs containing the same as the active ingredient |
| 08/30/2001 | WO2001062724A1 Prostaglandin e derivatives |
| 08/28/2001 | CA2054738C 15-deoxyprostaglandin derivatives |
| 08/23/2001 | US20010016597 Hypotensive agents; vision defects |
| 08/16/2001 | WO2001058866A2 Ocular hypotensive lipids |
| 08/16/2001 | US20010014693 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 08/16/2001 | CA2400323A1 Ocular hypotensive lipids |
| 08/09/2001 | WO2001057015A1 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
| 08/09/2001 | US20010012907 Chemical intermediates of prostaglandine produced by acidolysis, epoxidatin, oxidation, dehalogenation, cyclizaiton, etc... |
| 08/07/2001 | CA2073342C Transmetalations from zirconium to copper intermediates |
| 08/02/2001 | WO2001055102A1 Novel difluoroprostaglandin derivative |
| 08/02/2001 | WO2001055101A2 A new process for the preparation of latanoprost |
| 08/02/2001 | CA2398304A1 A new process for the preparation of latanoprost |
| 07/24/2001 | US6265440 Prostaglandins E and anti ulcers containing same |
| 07/17/2001 | US6262293 ω-Cycloalkly-prostaglandin e2 derivatives |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/11/2001 | EP1114816A1 $g(v)-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/11/2001 | CN1303370A Prostaglandin derivative |
| 07/11/2001 | CN1303292A 睡眠诱发剂 Sleep-inducing agent |
| 07/10/2001 | US6258844 Hypotensive agents for vision hypertension in mammals |
| 07/04/2001 | EP0825980B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 07/04/2001 | EP0783308B1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 06/28/2001 | WO2001046134A1 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE |
| 06/27/2001 | EP0938472B1 15-fluoro prostaglandins as ocular hypotensives |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248773 Vision defects |
| 06/19/2001 | CA2027351C Emulsion of lipid containing a prostaglandin analogue |
| 05/22/2001 | US6235780 ω-cycloalkyl-prostaglandin E1 derivatives |
| 05/22/2001 | US6235779 Use of cis-Δ4 analogs of prostaglandins as ocular hypotensives |
| 05/16/2001 | CN1295560A C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 05/16/2001 | CN1295559A C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists |
| 05/15/2001 | US6232344 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension |
| 05/09/2001 | EP1097922A1 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 05/01/2001 | US6225347 For lowering blood pressure, inhibiting platelet aggregation, for luteolytic effect, healing ulcer, inhibiting gastric acid secretion, as cytoprotective agent |
| 04/25/2001 | CN1292780A Novel process |
| 04/11/2001 | EP1089970A2 Oxidation inhibitors for prostane derivatives |
| 04/11/2001 | CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents |